[The effect of steroid therapy on cellular reactions in vivo in patients with cutaneous and systemic forms of erythematosus].
We examined 104 patients divided in two groups: patients suffering from lupus erythematosus systemic (SLE) and from lupus erythematosus cutaneous (CLE). Cellular immunity tests in vivo were performed in all patients: DNCB, PPD, Trichophytin, Candidin. Cellular immunity response were compared according to undergoing steroid therapy. Patients suffering from CLE had decreased reaction to cellular immunity test with increased dose of steroid therapy. In patient with SLE this decrease was not recognised.
Bukvić-Knor
T
T
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000941:Antigens / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy / Q000276:immunology*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology*; D008875:Middle Aged; D011241:Prednisone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012882:Skin Tests
D000941:Antigens; C063340:Nisone; D011241:Prednisone
Uticaj steroidne terapije na celularne reakcije in vivo kod pacijenata sa kutanom i sistemnom formom eritematodesa.